Article: Questran purchases sue Rohm & Haas in Philadelphia.

QUESTRAN PURCHASERS SUE ROHM & HAAS IN PHILADELPHIA

PHILADELPHIA, April 14 /PRNewswire/ -- Two purchasers of an anti- cholesterol drug provided by the Philadelphia-based drug company, Rohm & Haas Co. (NYSE: ROH), commenced class actions against it in federal court here.

The lawsuits were brought on behalf of purchasers of the drug Questran, frequently prescribed for heart patients, and other Rohm & Haas products containing cholestyramine resin. The plaintiffs allege that these drugs were sold as being unadulterated pharmaceutical products when, in fact, they were contaminated with the pesticide Dicofol and other chemicals.

Richard D. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!